SCHEMBL28355878

SCHEMBL28355878

O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)NC1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
TSHR P16473 3/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56
CASP1 P29466 1/20 0.56
CYP2C19 P33261 1/20 0.56
RECQL P46063 1/20 0.56
SLC8B1 Q6J4K2 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.43
CACNB4 O00305 1/20 0.43
CACNA1A O00555 1/20 0.43
CACNA1G O43497 1/20 0.43
CACNG3 O60359 1/20 0.43
CACNA1F O60840 1/20 0.43
CACNA1H O95180 1/20 0.43
CACNB3 P54284 1/20 0.43
CACNA2D1 P54289 1/20 0.43
CACNG7 P62955 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5177430 0.82 MAPT (0.50) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL13981274 0.78 TSHR (0.52) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL10371606 0.76 MAPT (0.44) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL5435436 0.76 MAPT (0.56) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL28470317 0.74 KMT2A (0.41) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL8117192 0.73 MAPT (0.60) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL31444453 0.73 ALDH1A1 (0.60) TSHRTP53RECQLSMN1; SMN2KDM4E
SCHEMBL31071906 0.72 TP53 (1.00) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL869274 0.72 TP53 (1.00) MAPTTSHRTP53CYP1A2CYP2C9
SCHEMBL10929981 0.70 MAPT (0.77) MAPTTSHRTP53CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110790714-A Preparation process of lorazepam impurity D 华中药业股份有限公司 2020-02-14 CN disclosed